Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Insight Molecular Diagnostics Inc. (IMDX)

Healthcare Diagnostics & Research
4.70 $
+1.1% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Insight Molecular Diagnostics Inc. (IMDX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 30.9% of the shares are freely tradable; institutional investors hold 61.4%.

Ownership Structure

Institutional ownership
61.4%
Insiders
20.4%
Float
30.9%
Short % of float
7.2%
Shares Outstanding
32Mio.

Largest Shareholders

Institutions

Institutions IMDX
Name Stake (%) Shares Change (%) Date
BROADWOOD CAPITAL Inc 36.95 11,931,839 +4.6 03/31/2026
Awm Investment Company Inc 8.69 2,806,256 -0.3 03/31/2026
PURA VIDA INVESTMENTS, LLC 2.93 947,134 +0.0 03/31/2026
Alyeska Investment Group, L.P. 2.60 840,777 +0.0 03/31/2026
Vanguard Capital Management, LLC 1.66 537,161 +0.0 03/31/2026
Vanguard Group Inc 1.63 526,675 +8.2 12/31/2025
Heights Capital Management Inc 1.22 392,545 +0.0 03/31/2026
Geode Capital Management, LLC 0.81 262,053 +13.5 03/31/2026
FNY Investment Advisers, LLC 0.77 247,421 +509.7 03/31/2026

Funds

Funds IMDX
Name Stake (%) Shares Change (%) Date
Vanguard Total Stock Mkt Idx Inv 0.92 297,775 +0.0 04/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
20. Apr 2026 Broadwood Partners, L.P. Major Shareholder Buy 40,690 3.88 157,877
17. Apr 2026 Broadwood Partners, L.P. Major Shareholder Buy 40,114 3.57 143,207

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?